Product
64Cu-DOTA-AE105
1 clinical trial
1 indication
Indication
Prostate CancerClinical trial
An Open-label, Two-part, Phase 2 Clinical Trial to Investigate the Safety and Diagnostic Performance of uPAR PET Imaging for Non-invasive Classification of ISUP Grades Among Patients With Localised, Untreated Prostate Cancer.Status: Recruiting, Estimated PCD: 2025-09-01